Armstrong and colleagues showed that infant MLL-ALL cells express higher levels of Fms-like tyrosine kinase 3 (FLT3) compared to MLL-germline ALL and that high expression of FLT3 in MLL-ALL correlates with poor prognosis [13]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.